BK vs EOLS · P/E 17, rev $20.08B vs rev $266.3M
The Bank of New York Mellon Corporation (BK) versus Evolus Inc (EOLS) — a side-by-side from cached financials, not a winner call.
The Bank of New York Mellon Corporation (BK) is a banks - diversified company listed on US.
Evolus Inc (EOLS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported BK revenue for 2025-12-31 was $20.08B. Net income was $5.55B. Revenue was up 7.8% from 2024-12-31 to 2025-12-31. BK currently screens at market cap $94.14B and trailing P/E 17.0.
Latest reported EOLS revenue for 2024-12-31 was $266.3M. Net income was -$50.4M. Revenue was up 31.8% from 2023-12-31 to 2024-12-31. EOLS currently screens at market cap $597.0M.
BK currently screens at market cap $94.14B and trailing P/E 17.0. EOLS currently screens at market cap $597.0M.
Not investment advice. Open the BK and EOLS stock pages for the full models.
Not investment advice.